Digital
12th - 14th October 2021

6th Annual MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference (EST TIME ZONE)

Leveraging next gen technologies beyond conventional biomarker drug discovery

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

The 6th Annual MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference scheduled to be held from 12th - 15th October 2021 would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

WHAT TO EXPECT

Key Highlights

  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers
  • Biomarker Drug Discovery and Assay Development
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases

Who Should Attend?

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers

CONFERENCE AGENDA
INNOVATIONS IN BIOMARKER RESEARCH: DIGITAL BIOMARKERS AND PREDICTIVE BIOMARKERS
IMMUNO-ONCOLOGY BIOMARKERS & DESIGN OF CLINICAL TRIALS IN CDX
CONFERENCE SPEAKERS
Speakers
Shashi Ramaiah
Shashi Ramaiah
Head, Safety Biomarkers, Translational Sciences, Pfizer
Paul Keown
Paul Keown
Professor of Medicine, University of British Columbia
 Maria Orr
Maria Orr
Head of Precision Medicine, AstraZeneca
Yinghui Zhou
Yinghui Zhou
Senior Director, Translational Strategy, Bayer
 Chetan Deshpande
Chetan Deshpande
Biomarker Operations Lead, Pfizer
Jim Christian
Jim Christian
Pathologist, Companion Diagnostics, Agilent Technologies
Jijumon Chelliserry
Jijumon Chelliserry
Senior Manager, Biomarker Clinical Assay Lead, Pfizer
Mark Verardo
Mark Verardo
Senior Scientific Program Manager, Agilent Technologies, USA
SPONSORS
Platinium
example-image

Agilent

example-image

Natera

Gold
example-image

Proteome Sciences

example-image

Owlstone Medical

example-image

NeoGenomics

Speaking Partner
example-image

Sysmex

example-image

PHC Group

example-image

Predicine

example-image

Arima Genomics

PARTNERS
Supporting Association
Georgia Bio

Georgia Bio

Media Partners
example-image

PharmaVOICE

example-image

Pharma Journalist

example-image

HealthEconomics.Com

example-image

This Week in Digital Health

example-image

The Journal of mHealth

example-image

IDDB Journal

PAST EVENT GALLERY